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Abstract
Background: The human cerebral microvascular endothelial cell line, hCMEC/D3, has been used extensively to
model the blood–brain barrier (BBB) in vitro. Recently, we reported that cytokine-treatment induced loss of brain
endothelial barrier properties. In this study, we further determined the gene expression pattern of hCMEC/D3 cells
in response to activation with TNFα and IFNγ.
Findings: Using a microarray approach, we observed that expression of genes involved in the control of barrier
permeability, including inter-brain endothelial junctions (e.g. claudin-5, MARVELD-2), integrin-focal adhesions
complexes (e.g. integrin β1, ELMO-1) and transporter systems (e.g. ABCB1, SLC2A1), are altered by pro-inflammatory
cytokines.
Conclusions: Our study shows that previously-described cytokine-induced changes in the pattern of gene
expression of endothelium are reproduced in hCMEC/D3 cells, suggesting that this model is suitable to study
inflammation at the BBB, while at the same time it has provided insights into novel key molecular processes that
are altered in brain endothelium during neuroinflammation, such as modulation of cell-to-matrix contacts.
Keywords: Blood–brain barrier, Transcriptome, Cytokines, Transporter systems, Inter-brain endothelial junctions,
Integrin-focal adhesions
Findings
Introduction
Cerebral endothelial cells (CEC) constitute the major
element of the highly specialized vasculature of the central
nervous system (CNS) that contributes to the blood–brain
barrier (BBB). In vitro models have complemented animal
and human studies in our current understanding of BBB
function. To date, the best characterized in vitro human
BBB model is based on the human cerebral microvascular
endothelial cell line, hCMEC/D3. Indeed, recent studies
on hCMEC/D3 cells have elucidated bacterial and viral
CNS invasion mechanisms [1,2], leukocyte trafficking [3],
regulation of transporters [4,5] and signalling pathways
controlling CEC paracellular permeability [6-9]. Here, we
provide further insights into the molecular mechanisms
associated with barrier dysfunction by analyzing the gene
expression pattern in cytokine-activated hCMEC/D3 cells
using mRNA microarray analysis.
Materials and methods
Culture conditions
hCMEC/D3 cells were cultured in EGM-2 MV medium
(Lonza, Slough Wokingham, UK) and supplemented with
the following components obtained from the manufac-
turer: 0.025% (v/v) rhEGF, 0.025% (v/v) VEGF, 0.025% (v/v)
IGF, 0.1% (v/v) rhFGF, 0.1% (v/v) gentamycin, 0.1% (v/v)
ascorbic acid, 0.04% (v/v) hydrocortisone and 2.5% (v/v)
foetal bovine serum (FBS). Cells were seeded onto flasks
supplied by Greiner Bio-one (Gloucestershire, UK), previ-
ously coated with collagen, and maintained at 37°C in 95%
air and 5% CO2 until confluence.
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RNA extraction and mRNA microarray analysis
hCMEC/D3 cells were grown on collagen-coated six-well
plates and treated with 10 ng/ml of TNFα and IFNγ (R&D
systems, Abingdon, Oxon, UK) for 24 h, while control cells
received the vehicle solution. Cells were washed once with
pre-warmed Hank’s balanced salts solution. Total RNA from
three biological replicates was isolated using miRNeasy mini
kit (Qiagen, Crawley, West Sussex, UK) according to the
manufacturer’s protocols. The RNA was re-suspended using
RNase-free water. The quantity (NanoDrop 1000 spectro-
photometer) and the quality (2100 Bioanalyzer, RNA 6000
Pico LabChip; Agilent, Palo Alto, CA, USA) were assessed
for each RNA sample. For each biological sample 100 ng of
total RNA was used, obtained from approximately 1.5 ×106
cells. For mRNA profiling, Ambion® TotalPrep 96 RNA
Amplification kit and Illumina hybridisation protocols
were carried out by Cambridge Genomic Services
(Cambridge, UK). The analysis was run using LUMI
and LIMMA packages (R Bioconductor). A quantile
normalization was performed and a number of quality
plots were generated to assess the quality of the data. Dif-
ferences between control and treated cells were estimated
when a gene signal in two or more replicates is at the back-
ground level. Instead of using numerical values, we indi-
cated these genes as upregulated (+) or downregulated (-)
in cytokine-treated cells. Detailed procedures and complete
data are available at the Gene Expression Omnibus (www.
ncbi.nlm.nih.gov/geo) under accession number GSE45880.
Quantitative RT-PCR
Complementary DNA was obtained using reverse tran-
scriptase (Promega, Madison, WI) with random primers
according to the manufacturer’s protocol. SYBR Green
real-time PCR (Qiagen, Manchester, UK) was used to de-
termine the relative levels of the genes analyzed (Table 1).
The reaction was then placed in a thermal cycler (DNA
engine Opticon 2; Bio-Rad, Hercules, CA, USA) using an
initial step at 95°C for 15 min, followed by 40 cycles (15 s
at 94°C, 30 s at 55°C, and 30 s at 72°C). The 2 –ΔΔCT
method was used for analysis of the data.
Table 1 Primers used for quantitative RT-PCR on hCMEC/D3 cells
Category Gene Forward and reverse primers Gene entrez Start Stop
Cell-cell contact CDH5 F: 5′CAGATCTCCGCAATAGACAAGG3′ NM_001795.2 1563 1585
R: 5′CGTGATTATCCGTGAGGGTAAAG3′ 1637 1660
MARVELD2 F: 5′GTACTCGTGGTTGCTGGATTAG3′ NM_001038603.2 840 862
R: 5′GCCACCAATTAGAGTCCAGAAG3′ 921 943
ANXA2 F: 5′GAAACAGCCATCAAGACCAAAG3′ NM_001002858.2 254 276
R: 5′TGGTAGGCGAAGGCAATATC3′ 335 355
Cell-to-matrix adhesion ITGB1 F: 5′CATGTTGTGGAGAATCCAGAGT3′ NM_002211.3 2367 2389
R: 5′GCAGTAATGCAAGGCCAATAAG3′ 2445 2467
ELMO1 F: 5′GACCTGGGTTGAGATGATATGG3′ NM_014800.10 4407 4429
R: 5′GAGTGCTCTGATGGGAAGAAG3′ 4483 4504
FHL2 F: 5′CAGAAACTCACTGGTGGACAA3′ NM_201555.1 792 813
R: 5′ATTCCTGGCACTTGGATGAG3′ 870 890
Chemokines/cell adhesion molecules CCL2 F: 5′GGCTGAGACTAACCCAGAAAC3′ NM_002982.3 13 34
R: 5′GAATGAAGGTGGCTGCTATGA3′ 108 129
VCAM-1 F: 5′CATTTGACAGGCTGGAGATAGA3′ M73255.1 1217 1239
R: 5′CTCTTGGTTTCCAGGGACTT3′ 1297 1317
CEACAM1 F: 5′CTACCTGTAGGATCAGGGTCTAA3′ NM_001712.4 1991 2014
R: 5′CTAGTTGCTTCTAGTGGGTTCTC3′ 2069 2092
Transporters ABCB1 F: 5′TGCAGGTACCATACAGAAACTC3′ NM_000927.4 3264 3286
R: 5′ACCGGAAACATCCAGCATAG3′ 3349 3369
SLC2A1 F: 5′GGACAGGCTCAAAGAGGTTATG3′ NM_006516.2 3217 3239
R: 5′AGGAGGTGGGTGGAGTTAAT 3′ 3309 3329
SLC2A3 F: 5′CTTAGTTCTCACTGTTCCCTCTG3′ NM_006931.2 3397 3420
R: 5′TCCCAAAGTGCTGGGATTAC3′ 3480 3500
Internal standard ACTB F: 5′GGACCTGACTGACTACCTCAT 3′ NM_001101.3 633 654
R: 5′CGTAGCACAGCTTCTCCTTAAT 3′ 718 740
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Bioinformatic analysis
DAVID bioinformatics [10] tool was used to create the
functional annotation clustering from microarray ana-
lysis by using KEGG pathways. Transcripts with more
than one probe represented in the mRNA microarray
that showed contradictory results in the direction of
changes in expression levels between control cells and
cells treated with TNFα and IFNγ, were considered as
not showing any changes.
Statistical analysis
The statistical analysis for the mRNA microarray was
performed using pairwise comparisons and false discov-
ery rate. The data set was filtered before normalisation,
removing any probes that were not successfully detected
(detection P was less than 0.01) in at least one sample.
Statistical significance was considered if P was less than
0.01 for KEGG analysis or 0.05 for barrier-related gene
analysis determined by LIMMA software. For quantita-
tive RT-PCR, statistical significance was considered if P
was less than 0.05 as determined by paired, one-tailed
Student’s t test.
Results
Pro-inflammatory cytokine modulation of gene
expression profile of cultured human brain endothelium
In order to identify the major molecular processes in-
volved in cytokine-induced altered CEC phenotype, we an-
alyzed the changes in gene expression in hCMEC/D3 cells
after stimulation with TNFα and IFNγ for 24 h using
mRNA array. By considering the transcripts that were
positively regulated with at least a two-fold change over
unstimulated cells (404 genes, P < 0.01) we identified three
statistically significant biological process associated with
antigen presentation (human leukocyte antigen, HLA)/cel-
lular adhesion (cell adhesion molecules, CAM) (20 genes),
cytokine/chemokine activity (28 genes) and cytokine-
induced signalling pathways (16 genes) (Additional file 1:
Table S1 TNFα and IFNγ-induced modulation of gene ex-
pression profile of cultured human brain endothelium).
Other minor functional categories identified were associ-
ated with apoptosis [11] and complement/coagulation cas-
cades [12] (Additional file 1: Table S1). In addition,
Additional file 1: Table S1, shows cytokine-induced in-
crease of 24 mRNA transcripts associated with interleukin
and decrease of 7 genes in hCMEC/D3 cells. We validated
cytokine-induced changes in the levels of 3 mRNAs in
hCMEC/D3 cells including CCL2, VCAM-1 and
CEACAM-1 (Figure 1A). Overall, these results indicate
that proinflammatory cytokines trigger changes in the
gene expression pattern of hCMEC/D3 cells with roles in
facilitating leukocyte adhesion and transmigration across
the brain endothelium.
Pro-inflammatory cytokine modulation of transcripts
related to BBB permeability
Recently, we reported that TNFα alone or in combin-
ation with IFNγ trigger signalling pathways that result
in loss of barrier properties by negative modulation of
cell-cell contacts [8]. Hence, we investigated genes in-
volved in the control of the paracellular pathway of
brain endothelium. Additional file 2: Table S2 (TNFα and
IFNγ-induced modulation of transcripts related to BBB
permeability) shows cytokine-induced decrease of 27
mRNA transcripts associated with the junctional complex
molecules (JCM), and an increase of 14 genes in hCMEC/
D3 cells. Furthermore, brain endothelial barrier properties
may be determined by cellular attachment to the extracel-
lular matrix [13]. We observed that stimulation with
TNFα and IFNγ induced changes in the expression pat-
tern of focal adhesion (FA) genes in hCMEC/D3 cells. Cy-
tokines reduced the expression of 45 transcripts and
increased of 43 transcripts out of the 126 FA genes identi-
fied in hCMEC/D3 cells (Additional file 2: Table S2). In
addition, 10 integrin genes out of the 18 integrin tran-
scripts identified in hCMEC/D3 cells were downregulated
by cytokines, whereas only integrin-αv was increased. The
qRT-PCR analysis confirms the downregulation of 6 genes
associated with cell-cell contacts and cell-matrix adhesion
(Figure 1B, 1C).
Another category that defines the functionality of BBB is
the expression of transporters. We observed that TNFα
and IFNγ reduced the expression of 50 transporters at the
mRNA level, including ABCB1 (P-glycoprotein, P-gp),
ABCG2 and SLC2A1 (Glut-1) (Figure 1D, Additional
file 2: Table S2). Conversely, 25 mRNA transcripts that
code for transporters were increased, including the
chemoresistant tranporter ABCB8 and the glucose trans-
porter SLC2A3 (Glut-3) (Figure 1D, Additional file 2:
Table S2). These results indicate that TNFα and IFNγ
remarkably affect the brain endothelial gene expression
pattern of cell-cell contacts, cell-matrix adhesion and
transport barrier systems.
Discussion
Here we showed an over-view of the cellular process altered
in cytokine-activated brain endothelium using mRNA array
analysis. Previous studies have shown that microvascular
and macrovascular human endothelium have several differ-
ences in response to inflammatory stimulus however some
similarities are also shared [12,14]. In our analysis, we ob-
served that some of the early changes in the gene expres-
sion pattern induced by TNFα in HUVECs [11,12,14] were
also seen during long-term exposure to TNFα and IFNγ in
hCMEC/D3 cells. These include the positive regulation of
chemokines, CAMs, apoptosis genes, complement and co-
agulation cascades [11,12,14]. Furthermore, among the
CAMs upregulated by TNFα and IFNγ we identified
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CEACAM-1, a molecule involved in angiogenesis and vas-
cular permeability [15], although its role in brain endothe-
lial barrier function have not been explored yet. In
addition, we recently reported that the ability of CEC to re-
spond to inflammatory stimuli by changing the pattern of
gene expression is in part controlled by transcriptional ac-
tivity [8,9] and in part at the post-transcriptional level via
small non coding RNAs termed microRNAs [16,17]. For
instance, miR-155 overexpression in hCMEC/D3 cells re-
flects the activated state of CEC induced by TNFα and
IFNγ, these include upregulation of genes associated with
antigen presentation, CAMs, complement pathways, cyto-
kine activity and barrier breakdown [17].
One molecular mechanism associated with cytokine-
induced endothelial barrier dysfunction is reorganization
of both cytoplasmic and transmembrane JCM from the
cell-cell contacts [8,18]. Here, we observed by gene ex-
pression profiling in hCMEC/D3 cells that stimulation
with TNFα and IFNγ for 24 h altered mRNA levels of
several JCM including claudin-5 and MARVELD-2 (also
known as tricellulin), both previously reported to be
enriched in CECs [19]. Indeed, we recently reported that
changes in paracellular permeability and transendothelial
electrical resistance correlated with changes in the expres-
sion of claudin-5 at the transcript and protein level [8,9].
Another molecular mechanism associated with loss of
endothelial barrier integrity is rearrangement of integrin-
focal adhesion complexes [20,21]. Our data supports the
hypothesis that FA constitute a novel pathway that is crit-
ical for BBB maintenance [13] as many FA components
were modulated by cytokines in CECs. For instance, integ-
rin ß1 serves as a platform to establish focal contacts and is
downregulated by cytokines in hCMEC/D3 cells. In
addition, loss of integrin ß1 might also affect claudin-5 pro-
tein levels [22] and thus the brain endothelial barrier [8].
We have considered some potential criticisms of the in-
terpretations given above. First, high concentrations of
TNFα and IFNγ induce an increase in CEC paracellular
permeability associated with caspase-3/-7 activation and
apoptotic cell death [8]. We cannot discard the possibility
Figure 1 Validation of mRNA microarray findings by quantitative RT-PCR. Levels of 12 genes selected for validation were determined by
quantitative RT-PCR (qRT-PCR). qRT-PCR data parallel that from the mRNA microarray analysis for genes associated with (A) chemokines/CAMs, (B)
cell-cell contacts, (C) cell-matrix adhesion, and (D) transporters. Control values were normalized to one and results are expressed as levels in
cytokine-treated cells relative to those in unstimulated cells. Actin-β was used as an internal standard. *P < 0.05, **P < 0.01, ***P < 0.001 compared
to unstimulated cells. Note that for ELMO and MARVELD2 the signal intensity in cytokine-treated cells was detected at the background level in
the mRNA microarray analysis.
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that some of the effects observed in this analysis might be
secondary to a small loss of cell viability. However, our
gene expression profile and the altered expression of BBB-
associated genes in hCMEC/D3 cells after cytokine treat-
ment correlate well with a recent report [23]. A second
possible drawback is that most of the changes in the gene
expression pattern reported here need to be further vali-
dated. However, the altered levels observed in 12 genes
after cytokine-treatment within 4 functional pathways
were validated by qRT-PCR. We observed that three genes
analyzed, ELMO1, ITGB1 and ABCB1, were always
downregulated after cytokine-treatment, but their fold
changes were variable. In addition, some of the functional
consequences of TNFα and IFNγ on CEC have been
reported. For instance, in agreement with our findings,
Poller et al. [4] showed that TNFα reduced expression of
BCRP (ABCG2) mRNA levels, protein levels and func-
tional activity [4]. Additionally, we previously demon-
strated that CCL2, CXCL10 and CCL5 protein expression
is upregulated by stimulation with TNFα and IFNγ in
hCMEC/D3 cells [24] and that these chemokines have
also been detected in MS plaques [24]. Similar to our re-
sults Pan et al. [25] reported that TNFα induced an in-
creased in IL-15 and its receptor, IL15RA, in rat brain
endothelial cells suggesting an important role of this inter-
leukin in the brain endothelial response to cytokines [25]
that is conserved between species.
In summary, pro-inflammatory cytokines might alter
the highly selective barrier permeability of brain endothe-
lial cells by establishing a new pattern of gene expression.
Changes in expression of CEC genes involve biological
processes associated with regulation of leukocyte infiltra-
tion, inter-brain endothelial junctions, integrin-focal adhe-
sions and transport systems. This analysis provides insight
into key molecular and cellular processes altered during
neuroinflammation.
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